Skip to content

Gyre Therapeutics, Inc. GYRE Intangible assets — net

Intangible assets — net at other companies

Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
Gilead Sciences logo
Gilead SciencesGILD

Other financials

Income statement

See full
Revenue$22.5M+2.1%
Gross profit$21.3M+0.6%
Operating income-$9.4M-512%
Net income-$8.7M-422%
EPS (diluted)-$0.10

Balance sheet

See full
Cash & equivalents$37.5M+149%
Total debt$823.0K-48.1%
Total equity$101.3M+48.7%
Total assets$162.0M+24.8%

Cash flow

See full
Operating cash flow$3.2M+2,565%
CapEx$178.0K+45.9%
Free cash flow$3.0M+1,296%

Valuation

See full
Market cap$694.58M-4.7%
Enterprise value$657.9M-8.0%
P/S5.9×-1.3×

Profitability

See full
Gross margin95.1%-1.1pp
Operating margin-0.1%-10.4pp
Net margin6.3%+3.3pp
FCF margin2.6%

Returns & leverage

See full
Return on equity8.2%+4.2pp
Debt / equity0.0×
Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s intangible assets — net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s intangible assets — net?
Gyre Therapeutics, Inc. (GYRE) reported intangible assets — net of $4.63M in Q1 2026.
How has Gyre Therapeutics, Inc.'s intangible assets — net changed year-over-year?
Gyre Therapeutics, Inc.'s intangible assets — net decreased by 9.0% year-over-year, from $5.08M to $4.63M.
What is the long-term trend for Gyre Therapeutics, Inc.'s intangible assets — net?
Over 3 years (2022 to 2025), Gyre Therapeutics, Inc.'s intangible assets — net has grown at a 151.5% compound annual growth rate (CAGR), from $297K to $4.73M.